Top 3 stocks to buy or sell tomorrow: Divis Lab, MCX, Maruti Suzuki by Chandan Taparia - Check stop-loss, targets
BSE moved lower.
24 Sept 2026 · LiveMint Markets
Domestic benchmark indices faced their steepest decline in 10 weeks, primarily due to rising crude oil prices and investor concerns. The Nifty 50 fell 1.64%, while the BSE Sensex dropped 1.67%. Financial stocks led the downturn amid worries over insurance commission limits.
The analysis
BSE reported movement of 1.64% and 1.67%. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is +0.3% on the day at ₹9,576.50, and has returned +41.5% over three months. It is trading close to its 52-week high, so expectations were already elevated going in. The pharma & healthcare sector has moved -0.7% over the same period, so Divi's Laboratories is running 42.2 points ahead of its peers.
This is an Input cost / crude event. India imports most of its crude, so input costs pass through to margins downstream and to the rupee. Producers and consumers of the same input move in opposite directions. On the day the stock is +0.3%, so the price barely moved, which suggests this was expected or is seen as immaterial.
Why it matters
- With BSE involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- The company directly in focus is DIVISLAB.
- Sector exposure: Pharma & Healthcare, Auto.
- The immediate tone of coverage reads negative.
In this story
Related coverage
Taking Stock: Market fails to hold on to day#39;s gains, ends marginally higher
Tata Motors PV, Maruti Suzuki, Ashok Leyland, auto stocks drop up to 3% as RBI signals rate cuts are ‘off the table’
Maruti Suzuki Share Price Live Updates: Maruti Suzuki's Current Market Price Analysis
Divi's Labs, TVS Motor could replace Max Healthcare, HDFC Life in Nifty 2027 index review
RBI rate hike impact: Bank, NBFC shares rebound; Auto, realty trade weak